SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN)
CUSIP: 868459108
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,671,650
- Total 13F shares
- 58,408,045
- Share change
- +1,703,628
- Total reported value
- $1,562,624,874
- Put/Call ratio
- 27%
- Price per share
- $26.75
- Number of holders
- 241
- Value change
- +$31,544,259
- Number of buys
- 115
- Number of sells
- 112
Quarterly Holders Quick Answers
What is CUSIP 868459108?
CUSIP 868459108 identifies SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 868459108:
Top shareholders of SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
18%
|
10,362,356
|
$353,459,964 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
6,206,814
|
$211,714,426 | — | 31 Mar 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
6.2%
|
3,572,000
|
$121,840,920 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
4.6%
|
2,668,996
|
$91,039,000 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
4.4%
|
2,556,921
|
$87,216,574 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.5%
|
2,038,646
|
$69,538,215 | — | 31 Mar 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
3.4%
|
1,940,510
|
$66,190,796 | — | 31 Mar 2024 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
3.3%
|
1,901,776
|
$64,869,579 | — | 31 Mar 2024 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
2.8%
|
1,597,417
|
$54,488,000 | — | 31 Mar 2024 | |
| GW&K Investment Management, LLC |
13F
|
Company |
2.3%
|
1,339,442
|
$45,688,000 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.3%
|
1,333,222
|
$45,476,000 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
1,306,950
|
$44,586,861 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
2.2%
|
1,291,291
|
$44,045,936 | — | 31 Mar 2024 | |
| Aristotle Capital Boston, LLC |
13F
|
Company |
2%
|
1,139,846
|
$38,880,142 | — | 31 Mar 2024 | |
| CONGRESS ASSET MANAGEMENT CO |
13F
|
Company |
1.8%
|
1,032,141
|
$35,206,330 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.7%
|
990,036
|
$33,588,255 | — | 31 Mar 2024 | |
| ASHFORD CAPITAL MANAGEMENT INC |
13F
|
Company |
1.3%
|
763,465
|
$26,041,791 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
650,226
|
$22,179,241 | — | 31 Mar 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.1%
|
647,838
|
$22,097,754 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
619,213
|
$21,121,356 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
1%
|
603,774
|
$20,594,731 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1%
|
592,646
|
$20,215,155 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.98%
|
566,270
|
$19,309,719 | — | 31 Mar 2024 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.9%
|
516,773
|
$17,627,127 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.77%
|
442,757
|
$15,103,000 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.73%
|
422,960
|
$14,427,171 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.63%
|
360,599
|
$12,300,032 | — | 31 Mar 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.62%
|
357,681
|
$12,200,499 | — | 31 Mar 2024 | |
| Tributary Capital Management, LLC |
13F
|
Company |
0.6%
|
344,838
|
$11,762,424 | — | 31 Mar 2024 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.57%
|
330,580
|
$11,276,112 | — | 31 Mar 2024 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.56%
|
320,920
|
$10,946,581 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.55%
|
314,894
|
$10,741,034 | — | 31 Mar 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.49%
|
283,996
|
$9,687,104 | — | 31 Mar 2024 | |
| SCOUT INVESTMENTS, INC. |
13F
|
Company |
0.46%
|
265,525
|
$8,900,398 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.4%
|
232,245
|
$7,921,877 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.39%
|
227,032
|
$7,744,062 | — | 31 Mar 2024 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.35%
|
202,993
|
$6,924,091 | — | 31 Mar 2024 | |
| Epoch Investment Partners, Inc. |
13F
|
Company |
0.35%
|
202,267
|
$6,899,327 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.34%
|
197,114
|
$6,723,563 | — | 31 Mar 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.32%
|
187,404
|
$6,380,413 | — | 31 Mar 2024 | |
| CW Advisors, LLC |
13F
|
Company |
0.31%
|
177,801
|
$6,064,789 | — | 31 Mar 2024 | |
| S&T BANK/PA |
13F
|
Company |
0.3%
|
175,564
|
$5,988,000 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.3%
|
174,461
|
$5,950,838 | — | 31 Mar 2024 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.3%
|
173,618
|
$5,922,110 | — | 31 Mar 2024 | |
| THIRD AVENUE MANAGEMENT LLC |
13F
|
Company |
0.28%
|
159,717
|
$5,447,947 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.27%
|
154,137
|
$5,257,612 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.25%
|
143,300
|
$4,887,963 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.23%
|
130,366
|
$4,446,784 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.22%
|
127,821
|
$4,359,974 | — | 31 Mar 2024 | |
| Phocas Financial Corp. |
13F
|
Company |
0.21%
|
118,542
|
$4,043,000 | — | 31 Mar 2024 |
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) as of Q2 2024
As of 30 Jun 2024,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) was held by
241 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,408,045 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, DIMENSIONAL FUND ADVISORS LP, MACQUARIE GROUP LTD, STATE STREET CORP, Polar Capital Holdings Plc, Stephens Investment Management Group LLC, RENAISSANCE TECHNOLOGIES LLC, and LOOMIS SAYLES & CO L P.
This page lists
241
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
246
Q2 2024 holders
241
Holder diff
-5
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.